ABRIZYL

Welcome to the Brand page for “ABRIZYL”, which is offered here for Anti-infectives; antibiotic preparations; antifungal preparations; antivirals; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology and for use in the gastroenterological area;.

Its status is currently believed to be active. Its class is unavailable. “ABRIZYL” is believed to be currently owned by “NOVARTIS AG”.